A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlume Biosciences, Inc.
About this trial
Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery
Eligibility criteria
Qualifiers
Must be a minimum of 18 years of age
Study participant is planning to proceed with surgery
Willing to provide informed consent
Sexually active patients must be willing to use an acceptable form of contraceptive while participating and 30 days after.
Disqualifiers
Patient has had prior surgery at the intended surgical site.
Patient has abnormal cardiac rhythm not controlled by medication.
Patient has moderate to severe renal impairment.
Patient has a history of fluorescein allergy.
Trial design
Treatments tested in this trial
- Bevonescein
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov